Determination of paromomycin in human plasma and urine by reversed-phase high-performance liquid chromatography using 2,4-dinitrofluorobenzene derivatization.
A sensitive high-performance liquid chromatographic method for the determination of paromomycin in human plasma and urine was developed. Paromomycin was quantitated following pre-column derivatization with 2,4-dinitrofluorobenzene (DNFB). The chromatographic separation was carried out on a C18 column at 50 degrees C using a mobile phase consisting of 64% methanol in water adjusted to pH 3.0 with phosphoric acid. The eluents were monitored by UV detection at 350 nm. The linearity of response for paromomycin was demonstrated at concentrations from 0.5 to 50 microg/ml in plasma and 1 to 50 microg/ml in urine. The relative standard deviation of the assay procedure is less than 5%.
Lu
J
J
Clinical Research Laboratory, College of Pharmacy, University of Illinois at Chicago, 60612, USA.
Cwik
M
M
Kanyok
T
T
D000900:Anti-Bacterial Agents / Q000097:blood* / Q000627:therapeutic use / Q000652:urine*; D002851:Chromatography, High Pressure Liquid; D004139:Dinitrofluorobenzene; D006801:Humans; D010303:Paromomycin / Q000097:blood* / Q000627:therapeutic use / Q000652:urine*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013056:Spectrophotometry, Ultraviolet
D000900:Anti-Bacterial Agents; D010303:Paromomycin; D004139:Dinitrofluorobenzene